ATE452903T1 - Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten - Google Patents

Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten

Info

Publication number
ATE452903T1
ATE452903T1 AT02797690T AT02797690T ATE452903T1 AT E452903 T1 ATE452903 T1 AT E452903T1 AT 02797690 T AT02797690 T AT 02797690T AT 02797690 T AT02797690 T AT 02797690T AT E452903 T1 ATE452903 T1 AT E452903T1
Authority
AT
Austria
Prior art keywords
treatment
autoimmune diseases
modified peptides
peptide
modified
Prior art date
Application number
AT02797690T
Other languages
English (en)
Inventor
Sylviane Muller
Fanny Monneaux
Jean-Paul Briand
Gille Guichard
Jean-Gerard Guillet
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE452903T1 publication Critical patent/ATE452903T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT02797690T 2001-09-06 2002-09-06 Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten ATE452903T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31773701P 2001-09-06 2001-09-06
PCT/IB2002/003606 WO2003020747A1 (en) 2001-09-06 2002-09-06 Modified peptides and their use for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
ATE452903T1 true ATE452903T1 (de) 2010-01-15

Family

ID=23235056

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02797690T ATE452903T1 (de) 2001-09-06 2002-09-06 Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten

Country Status (12)

Country Link
US (2) US20030186849A1 (de)
EP (2) EP1425295B1 (de)
JP (1) JP4108601B2 (de)
AT (1) ATE452903T1 (de)
AU (1) AU2002334258B2 (de)
CA (1) CA2459811C (de)
CY (1) CY1109946T1 (de)
DE (1) DE60234843D1 (de)
DK (1) DK1425295T3 (de)
ES (1) ES2338773T3 (de)
PT (1) PT1425295E (de)
WO (1) WO2003020747A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829768B1 (fr) 2001-09-18 2003-12-12 Centre Nat Rech Scient Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes
FR2931360B1 (fr) * 2008-05-20 2012-05-18 Centre Nat Rech Scient Nanoparticules contenant un peptide, vecteurs les contenant et utilisations pharmaceutiques desdits nanoparticules et vecteurs
WO2013088194A1 (en) * 2011-12-13 2013-06-20 Centre National De La Recherche Scientifique Modified peptides and their use for treating autoimmune diseases
US9872919B2 (en) * 2012-09-19 2018-01-23 The Research Foundation For The State University Of New York Prodrugs for selective anticancer therapy
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases
WO2021198135A1 (en) * 2020-03-29 2021-10-07 Immupharma France Sa Method of treating viral infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD205340A1 (de) * 1982-03-23 1983-12-28 Adw Ddr Verfahren zur herstellung von fett in wasser-emulsionen
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
DD240831A1 (de) * 1985-09-11 1986-11-19 Adw Ddr Verfahren zur gewinnung chemisch modifizierter proteine
US5561222A (en) * 1989-11-15 1996-10-01 Duke University RNA-binding proteins useful for the control of cellular genetic processing and expression
WO1995025124A1 (en) * 1994-03-14 1995-09-21 University Of Southern California Methods to diagnose and treat hiv-1 infection
US5527688A (en) * 1994-04-08 1996-06-18 Pierce Chemical Company Rapid assays for protein kinase activity
WO2000020583A1 (en) * 1998-10-08 2000-04-13 Zymogenetics, Inc. Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor
FR2829768B1 (fr) * 2001-09-18 2003-12-12 Centre Nat Rech Scient Utilisation de peptides comportant des modifications de type post-traductionnel dans le cadre du traitement de pathologies auto-immunes

Also Published As

Publication number Publication date
US20100047333A1 (en) 2010-02-25
WO2003020747A1 (en) 2003-03-13
AU2002334258B2 (en) 2008-08-21
DE60234843D1 (de) 2010-02-04
US20030186849A1 (en) 2003-10-02
ES2338773T3 (es) 2010-05-12
CA2459811C (en) 2012-03-13
JP4108601B2 (ja) 2008-06-25
JP2005512958A (ja) 2005-05-12
CY1109946T1 (el) 2014-09-10
EP2143730A3 (de) 2011-06-29
CA2459811A1 (en) 2003-03-13
PT1425295E (pt) 2010-03-24
EP2143730A2 (de) 2010-01-13
DK1425295T3 (da) 2010-05-03
EP1425295B1 (de) 2009-12-23
EP1425295A1 (de) 2004-06-09

Similar Documents

Publication Publication Date Title
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE410441T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidinanalogen
ATE368053T1 (de) Antimikrobielle peptide
BR0010720A (pt) Peptìdeos de neisseria antigênicos
ATE300619T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
EP1117682A4 (de) Peptide
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
ATE414099T1 (de) Biologisch aktive peptide
DE60329115D1 (de) Tumorantigenprotein und dessen verwendung
DE69534738D1 (de) Leukocyten-aktivierender Faktor
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
EP1467207A4 (de) Screening-verfahren
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
BR0107799A (pt) Proteìna de interação de wt1 wtip
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
ATE301199T1 (de) Beta-primeverosidase gen
WO2004058812A3 (en) Ribose-phosphate pyrophosphokinase polypeptides and structures

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1425295

Country of ref document: EP